Tanzania seeks self-sufficiency with local manufacture of ARVs

ARV pic

Dar es Salaam. Tanzania is making a strategic push to secure pharmaceutical independence, with the government unveiling plans to revive Tanzania Pharmaceutical Industries (TPI) in Arusha to produce antiretroviral (ARV) drugs locally.

Presenting the Health ministry’s Sh1.61 trillion budget estimates for 2025/26 in Parliament in Dodoma on Monday, Health minister Jenista Mhagama said the move was part of wider efforts to mitigate the impact of shifting international health funding priorities.